argenx NV ADRARGX
± MixedTechnologyrelevance
Hosting an R&D webinar on autoimmune myositis, but no specific data or results announced.
Impact on stocks 1
Health Care
argenx NV ADRargenx will host an R&D webinar on autoimmune myositis today, June 23, 2026, at 2:00pm ET. The event will feature argenx management and scientific leadership alongside key opinion leaders Avery LaChance of Harvard Medical School, Arjun Seth of Northwestern University Feinberg School of Medicine, and Rohit Aggarwal of the University of Pittsburgh and UPMC Myositis Center. A live webcast will be accessible on the Investors section of the argenx website, with a replay available for approximately one year. Supporting presentation slides will also be posted on the company's Events & Presentations website at the start of the event.
argenx NV ADRHosting an R&D webinar on autoimmune myositis, but no specific data or results announced.